We are live on ! Find out more
WC

Wexford Capital Portfolio holdings

AUM $690M
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+20.02%
1 Year Est. Return
+57.92%
3 Year Est. Return
+92.61%
5 Year Est. Return
10 Year Est. Return
AUM
$359M
AUM Growth
-$26M
Cap. Flow
-$65.8M
Cap. Flow %
-18.35%
Top 10 Hldgs %
47.08%
Holding
344
New
127
Increased
37
Reduced
53
Closed
104

Sector Composition

Rank Sector Weight
1 Industrials 21.99%
2 Materials 16.93%
3 Energy 14.66%
4 Healthcare 9.43%
5 Utilities 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVGO icon
176
Broadcom
AVGO
$1.85T
$175K 0.05%
636
-620
-49% -$135K
RZLT icon
177
Rezolute
RZLT
$454M
$171K 0.05%
+38,348
New +$142K
MTZ icon
178
MasTec
MTZ
$21.1B
$170K 0.05%
+1,000
New +$144K
CYTK icon
179
Cytokinetics
CYTK
$10.5B
$169K 0.05%
+5,107
New +$178K
ARQT icon
180
Arcutis Biotherapeutics
ARQT
$3.36B
$162K 0.05%
+11,558
New +$162K
VERA icon
181
Vera Therapeutics
VERA
$2.3B
$162K 0.05%
6,864
-35,441
-84% -$797K
AIT icon
182
Applied Industrial Technologies
AIT
$12.8B
$161K 0.05%
694
-454
-40% -$103K
MTSR
183
DELISTED
Metsera Inc
MTSR
$160K 0.04%
+5,633
New +$140K
OUST icon
184
Ouster
OUST
$2.63B
$160K 0.04%
+6,582
New +$80K
ACLX
185
DELISTED
Arcellx
ACLX
$159K 0.04%
2,420
-10,387
-81% -$647K
GLNG icon
186
Golar LNG
GLNG
$5B
$159K 0.04%
3,863
NUVB icon
187
Nuvation Bio
NUVB
$2.2B
$159K 0.04%
81,590
-691,329
-89% -$1.44M
APLS
188
DELISTED
Apellis Pharmaceuticals
APLS
$158K 0.04%
+9,139
New +$169K
SLN
189
Silence Therapeutics
SLN
$495M
$157K 0.04%
+27,149
New +$116K
ACOG
190
Alpha Cognition
ACOG
$180M
$155K 0.04%
+16,666
New +$122K
JANX icon
191
Janux Therapeutics
JANX
$925M
$151K 0.04%
+6,541
New +$172K
ARWR icon
192
Arrowhead Research
ARWR
$11.9B
$146K 0.04%
+9,229
New +$132K
STM icon
193
STMicroelectronics
STM
$46.7B
$144K 0.04%
+4,724
New +$117K
CGEM icon
194
Cullinan Oncology
CGEM
$1.01B
$141K 0.04%
+18,726
New +$150K
TKR icon
195
Timken Company
TKR
$9.56B
$140K 0.04%
+1,925
New +$131K
ALGM icon
196
Allegro MicroSystems
ALGM
$7.73B
$139K 0.04%
+4,070
New +$101K
ON icon
197
ON Semiconductor
ON
$31.8B
$135K 0.04%
+2,570
New +$112K
RRX icon
198
Regal Rexnord
RRX
$13.7B
$132K 0.04%
+912
New +$114K
CW icon
199
Curtiss-Wright
CW
$26.7B
$127K 0.04%
+260
New +$103K
KOF icon
200
Coca-Cola Femsa
KOF
$22.7B
$126K 0.04%
1,298
-57,214
-98% -$5.42M

Similar funds

Wexford Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Wexford Capital held 344 positions worth $359M, down 6.8% from $385M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Wexford Capital withdrew a net $65.8M in Q2 2025, closing 104 positions and reducing 53 holdings. Its most notable exit was US Steel, an estimated $29M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 17% a quarter earlier, followed by Materials and Energy.

Against the trend, Wexford Capital opened a new position in Vanguard FTSE Emerging Markets ETF worth $10.3M.

  • Wexford Capital's largest Q2 2025 buy was Vanguard FTSE Emerging Markets ETF: 209,092 shares worth $10.3M.
  • Wexford Capital added most to Comcast in Q2 2025, an estimated $7.26M increase.
  • Wexford Capital's biggest Q2 2025 reduction was Coca-Cola Femsa, cutting an estimated $5.42M.
  • Wexford Capital fully exited US Steel in Q2 2025, selling an estimated $29M.
  • Wexford Capital's ten largest holdings make up 47% of its $359M portfolio in Q2 2025.
  • Wexford Capital opened 127 new positions and closed 104 in Q2 2025.
  • Wexford Capital's portfolio value fell 6.8% quarter-over-quarter to $359M.

Based on Wexford Capital's 13F filing for Q2 2025, filed 14 Aug 2025.